View drug registration information details.


ItemsRegistration information
ID38
No38
Brand NameLEVOMET
IngredientsLEVODOPA 250 MG, CARBIDOPA MONOHYDRATE 27 MG EQ.TO CARBIDOPA 25 MG
Dosage FormTABLET
Primary PackagingALU-PVC/PVDC BLISTER
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 10 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF IDIOPATHIC PARKINSON'S DISEASE, POSTENCEPHALITIC PARKINSONISM, OR SYMPTOMATIC PARKINSONISM, WHICH MAY FOLLOW INJURY TO THE NERVOUS SYSTEM BY CARBON MONOXIDE INTOXICATION OR MANGANESE INTOXICATION, TO PERMIT ACHIEVEMENT OF SYMPTOMATIC RELIEF WITH A LOWER DOSAGE OF LEVODOPA THAN WITH LEVODOPA ALONE.
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionLIGHT BLUE, OVAL BICONVEX TABLET WITH SCORED ON ONE SIDE AND PLAIN ON THE OTHER
Note
License OwnerAI KEN PHARMA CO., LTD
ManufacturerUNISON LABORATORIES CO., LTD
CountryTHAILAND
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No12 I 3264/08
FDD Registration Date19-Apr-2023
Expiry Date18-Apr-2026

Back to drug list